“The solution provides our service with quantitative information invaluable for diagnosis, and enables a rationalization of the therapeutic decision-making process.”
- 40+ Clinical Studies
- 20+ Publications
- 2 Major Awards
- CE / FDA Cleared
“Pixyl.Neuro.MS has dramatically improved our ability to detect new lesions on follow-up MRIs, with greater accuracy and confidence. For the investigation of cognitive disorders, Pixyl.Neuro.BV provides reliable information and offers new insights to diagnose neurodegenerative diseases.”
“Pixyl has been an incredible asset to our Neuroradiology Section, optimizing daily workfow, reducing turnaround times and enhancing Radiology reports.”
1 — 3
Pixyl.Neuro in Action
See how our Pixyl.Neuro.MS AI accelerates the detection and monitoring of MS lesions, using T2-FLAIR and how our Pixyl.Neuro.BV quantifies atrophy over time to provide vital insights into disease progression and treatment planning.
Increase Reader Performance
Enhancing the sensitivity of T2-FLAIR imaging can improve lesion detection accuracy by up to 30%, leading to earlier diagnosis and more precise tracking of lesion evolution over time.
Supporting radiology workflows
Pixyl.Neuro.MR reduces average brain MRI reading times by up to 65% compared to standard methods, significantly accelerating diagnostic workflows and enhancing patient care.
